Luchino Chessa
Luchino Chessa
Department of Medical Sciences and Public Health University of Cagliari
Verified email at unica.it
Title
Cited by
Cited by
Year
Long-term benefit of interferon α therapy of chronic hepatitis D: regression of advanced hepatic fibrosis
P Farci, T Roskams, L Chessa, G Peddis, AP Mazzoleni, R Scioscia, ...
Gastroenterology 126 (7), 1740-1749, 2004
2822004
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome
P Farci, R Strazzera, HJ Alter, S Farci, D Degioannis, A Coiana, G Peddis, ...
Proceedings of the National Academy of Sciences 99 (5), 3081-3086, 2002
2472002
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
P Lampertico, M Viganò, GG Di Costanzo, E Sagnelli, M Fasano, ...
Gut 62 (2), 290-298, 2013
1192013
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy
MG Carta, MC Hardoy, A Garofalo, E Pisano, V Nonnoi, G Intilla, G Serra, ...
Clinical Practice and Epidemiology in Mental Health 3 (1), 22, 2007
1092007
Association of chronic hepatitis C with recurrent brief depression
MG Carta, J Angst, MF Moro, G Mura, MC Hardoy, C Balestrieri, L Chessa, ...
Journal of affective disorders 141 (2-3), 361-366, 2012
502012
Treatment of chronic hepatitis D
P Farci, L Chessa, C Balestrieri, G Serra, ME Lai
Journal of viral hepatitis 14, 58-63, 2007
472007
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin
C Cauli, G Serra, L Chessa, C Balestrieri, R Scioscia, ME Lai, P Farci
Haematologica 91 (6 Suppl), ECR26-ECR26, 2006
282006
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, ...
Hepatology 66 (6), 1814-1825, 2017
242017
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network
LA Kondili, GB Gaeta, MR Brunetto, A Di Leo, A Iannone, TA Santantonio, ...
PloS one 12 (10), 2017
182017
Exploring the role of killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis
R Littera, L Chessa, S Onali, F Figorilli, S Lai, L Secci, G La Nasa, ...
PLoS One 11 (1), 2016
182016
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver.
AP Gramenzi A, Conti F, Cammà C, Grieco A, Picciotto, AHES Group.
Digestive and Liver Disease 44 (8), 674-680, 2012
182012
Interferon-alpha-induced psychiatric side effects in patients with chronic viral hepatitis: a prospective, observational, controlled study
MG Orrù, A Baita, R Sitzia, A Costa, E Muntoni, S Landau, L Chessa, ...
Epidemiology and Psychiatric Sciences 14 (3), 145-153, 2005
172005
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV
A Karampatou, X Han, LA Kondili, G Taliani, A Ciancio, F Morisco, ...
Journal of hepatology 68 (1), 33-41, 2018
132018
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a …
S Petta, M Marzioni, P Russo, A Aghemo, A Alberti, A Ascione, A Antinori, ...
The Lancet Gastroenterology & Hepatology 2 (6), 427-434, 2017
132017
Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
LA Kondili, S Robbins, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, ...
Liver International 38 (12), 2190-2198, 2018
102018
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
AC Gardini, L Faloppi, G Aprile, O Brunetti, C Caparello, J Corbelli, ...
Tumori Journal 104 (6), 476-479, 2018
92018
Influence of alfa interferon on the natural history of chronic hepatitis D: Dissociation of histologic and virologic response.
P Farci, L Chessa, G Peddis, R Strazzera, E Pascariello, R Scioscia, ...
92000
Hépatite B
JM Pawlotsky, D Dhumeaux
L'Editeur: EDP Sciences, 2009
82009
Add‐on peginterferon alfa‐2a to nucleos (t) ide analogue therapy for Caucasian patients with hepatitis B ‘e’antigen‐negative chronic hepatitis B genotype D
P Lampertico, MR Brunetto, A Craxì, GB Gaeta, M Rizzetto, A Rozzi, ...
Journal of viral hepatitis 26 (1), 118-125, 2019
72019
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma
R Littera, F Zamboni, V Tondolo, G Fantola, L Chessa, N Orrù, M Sanna, ...
Human immunology 74 (10), 1288-1294, 2013
52013
The system can't perform the operation now. Try again later.
Articles 1–20